期刊文献+

不同MH琼脂对于替加环素对鲍曼不动杆菌药敏结果的影响 被引量:13

Effect of different Mueller-Hinton agars on tigecycline agar dilution susceptibility for Acinetobacter baumannii
下载PDF
导出
摘要 目的:观察不同厂家生产的MH琼脂(MHA)对于替加环素对鲍曼不动杆菌琼脂平板稀释法药敏结果的影响。方法 :采用琼脂平板稀释法分别测定应用Difco MHA、Oxoid MHA、美坛MHA和奥博星MHA时,替加环素对50株鲍曼不动杆菌的MIC值。结果:应用Difco MHA、Oxoid MHA、美坛MHA和奥博星MHA时的MIC90分别为2、4、4、16μg.mL-1。替加环素的敏感率分别为100%、6%、6%和0。结论:应用不同厂家的MHA进行琼脂稀释法药敏测定时,替加环素对鲍曼不动杆菌的敏感率具有明显的差别。 Objective: To study the effect of different Mueller-Hinton agars on tigecycline agar dilution susceptibility for Acinetobacter baumannii. Methods: Minimal inhibitory concentrations (MICs) of 50 isolates of A. baumannii were determined in parallel by the agar dilution method as described by the Clinical and Laboratory Standards Institute (CLSI), with four different MHAs: Difco, Oxoid, Meitan and Aaoboxing. Results: The MICg0 values of tigecycline on MHA (Difco), MHA (Oxoid), MHA (Meitan) and MHA(Aaoboxing) were 2, 4, 4,16 ltg'mLl, respectively. The susceptibility ofA. baumannii to tigecycline using MHA (Difco) was 100 %, whereas that using MHA (Oxoid), MHA (Meitan) and MHA(Aaoboxing) was only 6%, 6% and 0. Conclusion: There is significant effect of different Mueller-Hinton agars on tigecycline agar dilution susceptibility for Acinetobacter baumannii.
出处 《中国药物应用与监测》 CAS 2012年第2期84-86,共3页 Chinese Journal of Drug Application and Monitoring
基金 北京市自然科学基金资助项目(7112127 替加环素对多重耐药鲍曼不动杆菌的体外抗菌活性和耐药机制研究)
关键词 MH琼脂 替加环素 鲍曼不动杆菌 最低抑菌浓度 Mueller-Hinton agars Tigecycline Acinetobacter baumannii Minimal inhibitory concentration (MIC)
  • 相关文献

参考文献10

  • 1Kulah C,Celebi G,Aktas E. Unexpected tigecyclin resistance among Acinetobacter baumannii isolates:high minor errorrate by Etest[J].Journal of Chemotherapy,2009,(04):390-395.
  • 2Liu JW,Jang TN,Cheng YJ. Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan[J].International Journal of Antimicrobial Agents,2010,(02):201-202.
  • 3Navon-Venezial S,Leavittl A,Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii[J].Journal of Antimicrobial Chemotherapy,2007,(04):772-748.
  • 4Karageorgopoulos DE,Kelesidis T,Kelesidis 1. Tigecycline for the treatment of multidrug-resistant (including carbapenemresistant) Acinetobacter infections:a review of the scientific evidence[J].Journal of Antimicrobial Chemotherapy,2008,(01):45-55.
  • 5Curcio D,Fernandez F. Comment on:effect of different MuellerHinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp[J].Journal of Antimicrobial Chemotherapy,2008,(05):1166-1167.
  • 6Thamlikitkul V,Tiengrim S,Tribuddharat C. Comment on:high tigecycline resistance in multidrug-resistant Acinetobacter baumannii[J].Journal of Antimicrobial Chemotherapy,2007,(01):177-178.
  • 7孙谦,周宏伟,胡燕燕,陈功祥.多重耐药鲍曼不动杆菌对替加环素耐药状况分析[J].中华检验医学杂志,2011,34(4):358-362. 被引量:29
  • 8Thamlikitkul V,Tiengrim S. Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp[J].Journal of Antimicrobial Chemotherapy,2008,(02):847-848.
  • 9鲁刚,高辉,柴栋.重症监护病房院内感染致病菌及其耐药性研究[J].中国药物应用与监测,2008,5(3):14-16. 被引量:5
  • 10Casal M,Rodriguez F,Johnson B. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp[J].Journal of Antimicrobial Chemotherapy,2009,(01):69-72.

二级参考文献21

  • 1邓瑞莲,罗冰芬,游丽莎,刘心亮,邝慕珠.重症监护病房致病菌及其耐药性分析[J].中国医药导报,2007,4(01X):141-143. 被引量:2
  • 2方平,潘晓龙,周东升,吴祥林.耐亚胺培南鲍曼不动杆菌耐药机制研究[J].中国抗生素杂志,2007,32(4):245-248. 被引量:23
  • 3[1]Singh AK,Sen MR,Anupurba S,et al.Antibiotic sensitivity pattern of the bacteria isolated from nosocomial infections in ICU[J].J Commun Dis,2002,342(1):257-263.
  • 4Yang SC,Chang WJ,Chang YH,et al.Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan.Eur J Clin Microbiol Infect Dis,2010,29:601-604.
  • 5Mezzatesta ML,Trovato G,Gona F,et al.In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy.Ann Clin Microbiol Antimicrob,2008,7:1-7.
  • 6Livermore DM.Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:our worst nightmare? Clin Infect Dis,2002,34:634-640.
  • 7Somily AM.Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli.Saudi Med J,2010,31:507-511.
  • 8Liu JW,Wang LS,Cheng YJ,et al.In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.Int J Antimicrob Agents,2008,32:188-191.
  • 9Dizbay M,Ahuncekic A,Sezer BE,et al.Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.Int J Antimicrob Agents,2008,32:29-32.
  • 10Navon-Venezia S,Leavitt A,Carmeli Y.High tigecycllne resistance in multidrug-resistant Acinetobacter baumannii.J Antimicrob Chemother,2007,59:772-774.

共引文献32

同被引文献150

引证文献13

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部